Waldencast Acquisition Corp宣布，美国食品药品监督管理局(FDA)已批准其旗下Obagi Medical品牌的Obagi Saypha Magiq注射用透明质酸凝胶产品。
这款获得FDA批准的注射用透明质酸凝胶产品将在Obagi Medical品牌下进行销售，标志着公司在医美领域的重要进展。该产品的获批将为公司在美国市场的业务拓展提供新的增长机会。
Waldencast Acquisition Corp宣布，美国食品药品监督管理局(FDA)已批准其旗下Obagi Medical品牌的Obagi Saypha Magiq注射用透明质酸凝胶产品。
这款获得FDA批准的注射用透明质酸凝胶产品将在Obagi Medical品牌下进行销售，标志着公司在医美领域的重要进展。该产品的获批将为公司在美国市场的业务拓展提供新的增长机会。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.